Cell kinetics and therapy in multiple myeloma: an update of the M83 protocol

Bone Marrow Transplant. 1989 Jan:4 Suppl 1:168-9.
No abstract available

Publication types

  • Clinical Trial
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Bone Marrow / pathology
  • Carmustine / administration & dosage
  • Cell Cycle
  • Cyclophosphamide / administration & dosage
  • Diagnosis, Differential
  • Doxorubicin / administration & dosage
  • Drug Evaluation
  • Humans
  • Melphalan / administration & dosage
  • Multiple Myeloma / diagnosis
  • Multiple Myeloma / drug therapy
  • Multiple Myeloma / pathology*
  • Paraproteinemias / diagnosis
  • Plasma Cells / pathology*
  • Prednisone / administration & dosage
  • Prognosis
  • Random Allocation
  • Vincristine / administration & dosage

Substances

  • Vincristine
  • Doxorubicin
  • Cyclophosphamide
  • Melphalan
  • Carmustine
  • Prednisone

Supplementary concepts

  • AP protocol 2
  • VBAP protocol
  • VMCP protocol